Prognostic Significance of Cyclooxygenase 2 mRNA Expression in Non-Small Cell Lung Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
Real time quantitative PCR.
1996 • 6,155 citations
Revisions in the International System for Staging Lung Cancer
1997 • 4,582 citations
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 • 3,981 citations
Cancer statistics, 2000
2000 • 3,907 citations
CYCLOOXYGENASES 1 AND 2
1998 • 2,700 citations
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
1994 • 2,553 citations
Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
1996 • 2,387 citations
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 • 2,308 citations
A novel method for real time quantitative RT-PCR.
1996 • 2,093 citations
Aspirin Use and Reduced Risk of Fatal Colon Cancer
1991 • 1,695 citations
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
1997 • 1,411 citations
Expression of cyclooxygenase-1 and -2 in human colorectal cancer.
1995 • 1,135 citations
Expression of cyclooxygenase-2 in human gastric carcinoma.
1997 • 829 citations
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.
1998 • 825 citations
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
1994 • 746 citations
Expression of cyclooxygenase-2 in human lung carcinoma.
1998 • 729 citations
Cyclooxygenase-2 expression in human esophageal carcinoma.
1999 • 670 citations
Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast Cancer
1998 • 665 citations
Maximally Selected Chi Square Statistics
1982 • 480 citations
Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.
2000 • 322 citations
Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.
1999 • 315 citations
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence
2000 • 228 citations
Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
2000 • 205 citations
G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2.
1996 • 173 citations
The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention
1995 • 166 citations
Mechanism of action of aspirin-like drugs
1997 • 139 citations
Maximally Selected Chi Square Statistics for Small Samples
1982 • 121 citations
Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.
1998 • 106 citations
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer
2000 • 82 citations
Cyclooxygenase‐2 (COX‐2) mRNA Expression Levels in Normal Lung Tissues and Non‐small Cell Lung Cancers
1999 • 77 citations
Aspirin, NSAIDs, and digestive tract cancers
1994 • 72 citations
Cited By (0)
No citing papers found in database